Understanding Value in Metastatic Breast Cancer
Understanding Out-of-pocket Expenses and Patient Time Spent on Healthcare in Metastatic Breast Cancer Patients (Understanding Value in Metastatic Breast Cancer)
1 other identifier
observational
100
1 country
1
Brief Summary
The overall objective of this project is to gain knowledge about out-of-pocket (OOP) expenses and lost opportunity costs among metastatic breast cancer (MBC) patients. To achieve this objective, MBC patients will be asked to participate in a short, 37-question survey asking questions about the financial burden, OOP expenses, and opportunity costs related to their cancer care
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 13, 2017
CompletedFirst Submitted
Initial submission to the registry
July 26, 2017
CompletedFirst Posted
Study publicly available on registry
August 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2019
CompletedAugust 26, 2019
August 1, 2019
2 years
July 26, 2017
August 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-cancer diagnosis cost
based on a validated survey
2 years
Secondary Outcomes (9)
Time loss experienced by patients with metastatic breast cancer.
2 years
Do patient characteristics (sociodemographics, cancer characteristics, health status, healthcare utilization) influence the total cost of care or financial burden?
2 Years
Does treatment type (chemotherapy vs. hormone therapy) influence the total cost of care or financial burden?
2 years
What is the trajectory of financial burden or total cost of care over time (year pre-MBC diagnosis vs. post-MBC diagnosis)?
2 Years
Does financial burden or total cost of care influence treatment adherence?
2 years
- +4 more secondary outcomes
Interventions
The overall objective of this project is to gain knowledge about out-of-pocket (OOP) expenses and lost opportunity costs among metastatic breast cancer (MBC) patients. To achieve this objective, MBC patients will be asked to participate in a short, 37-question survey asking questions about the financial burden, OOP expenses, and opportunity costs related to their cancer care.
Eligibility Criteria
The participants will be derived from Metastatic Breast Cancer patients receiving care at UAB Kirklin Clinic.
You may qualify if:
- All female MBC patients 18 years of age and older who have received treatment within the past two years at UAB
You may not qualify if:
- Non-English speakers, patients residing in nursing homes or receiving hospice care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Alabama at Birminghamlead
- Genentech, Inc.collaborator
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gabrielle B Rocque, MD
Assistant Professor
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 26, 2017
First Posted
August 22, 2017
Study Start
June 13, 2017
Primary Completion
June 24, 2019
Study Completion
July 12, 2019
Last Updated
August 26, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share